Bacteria Marketing Reagent 
The Pharma Data
DECEMBER 2, 2020
aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. eTheRNA’s global programs will benefit from China Grand Pharma’s development, clinical and marketing input.
Roots Analysis
OCTOBER 16, 2023
Further, the labor and reagent cost incurred in cloning procedures is reduced with customized cloning. Future Perspectives of DNA Cloning The COVID 19 pandemic has had a significant impact on the DNA cloning market. Along with this, the high quality DNA clones and gene clones are customized as per the need and requirement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 14, 2020
Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. The funds will be used to bring Ori’s innovative manufacturing platform to the market. CARB-X will provide Polyphor with initial funding of up to $2.62 Source link.
The Pharma Data
DECEMBER 23, 2020
Marketing Authorization was based on the pivotal phase III ATLAS (Antiretroviral Therapy as Long-Acting Suppression), FLAIR (First Long-Acting Injectable Regimen) and ATLAS-2M studies. Astrea is a leading provider of affinity separation solutions to the pharmaceutical and biomanufacturing industries. It is a division of Gamma Biosciences.
Roots Analysis
JANUARY 27, 2025
The recent advancements in the field of protein expression, coupled with the launch of novel expression systems have emerged as the key drivers for the growing adoption of protein expression solutions in the overall pharma market. Want additional details on the market? Access our Protein Expression Market Report.
Expert insights. Personalized for you.
52 
Let's personalize your content